Tissue signatures influence the activation of intrahepatic CD8+ T cells against malaria sporozoites

Frontiers in Microbiology

Volumn 5, Issue AUG, 2014, Pages

  Morrot, Alexandre ^a   Rodrigues, Maurício M ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CD8+ T cells; Hepatocytes; Malaria liver stages; Migration and invasion; Vaccine

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; BLOOD VESSEL PERMEABILITY; BLOODSTREAM INFECTION; CD8+ T LYMPHOCYTE; DISEASE TRANSMISSION; GENE EXPRESSION; HUMAN; IMMUNITY; INTRAHEPATIC BILE DUCT; KNOWLEDGE; LIVER FUNCTION; MALARIA; MICROARRAY ANALYSIS; NONHUMAN; PLASMODIUM; REVIEW; SIGNAL TRANSDUCTION; SKIN INFECTION;

EID: 84987778365     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00440     Document Type: Review

References (108)

1. Alvarez, C., Kukutla, P., Jiang, J., Yu, W., and Xu, J. (2012). Draft genome sequence of Pseudomonas sp. strain Ag1, isolated from the midgut of the malaria mosquito Anopheles gambiae. J. Bacteriol. 194, 5449. doi: 10.1128/JB.01173-12
2. Amino, R., Giovannini, D., Thiberge, S., Gueirard, P., Boisson, B., Dubremetz, J. F., et al. (2008). Host cell traversal is important for progression of the malaria parasite through the dermis to the liver. Cell Host Microbe 3, 88-96. doi: 10.1016/j.chom.2007.12.007
3. Balam, S, Romero, J. F., Bongfen, S. E., Guillaume, P, and Corradin, G. (2012). CSP-a model for in vivo presentation of Plasmodium berghei sporozoite antigens by hepatocytes. PLoS ONE 7:e51875. doi: 10.1371/journal.pone.0051875
4. Beghdadi, W, Porcherie, A, Schneider, B. S., Dubayle, D, Peronet, R, Huerre, M, et al. (2008). Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease. J. Exp. Med. 205, 395-408. doi: 10.1084/jem.20071548
5. Bejon, P., Ogada, E., Mwangi, T., Milligan, P., Lang, T., Fegan, G., et al. (2007). Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. PLoS ONE 2:e707. doi: 10.1371/journal.pone.0000707
6. Birkett, A. J., Moorthy, V. S., Loucq, C., Chitnis, C. E., and Kaslow, D. C. (2013). Malaria vaccine R&D in the Decade of Vaccines: breakthroughs, challenges and opportunities. Vaccine 31(Suppl. 2), B233-B243. doi: 10.1016/j.vaccine.2013.02.040
7. Bruder, J. T., Semenova, E., Chen, P., Limbach, K., Patterson, N. B., Stefaniak, M. E., et al. (2012). Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses. PLoS ONE 7:e33920. doi: 10.1371/journal.pone.0033920
8. Butler, N. S., Schmidt, N. W., and Harty, J. T. (2010). Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites. J. Immunol. 184, 2528-2538. doi: 10.4049/jimmunol.0903529
9. Butler, N. S., Schmidt, N. W., Vaughan, A. M., Aly, A. S., Kappe, S. H., and Harty, J. T. (2011). Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe 9, 451-462. doi: 10.1016/j.chom.2011.05.008
10. Cabrera, M., Pewe, L. L., Harty, J. T., and Frevert, U. (2013). In vivo CD8+ T cell dynamics in the liver of Plasmodium yoelii immunized and infected mice. PLoS ONE 8:e70842. doi: 10.1371/journal.pone.0070842
11. Carvalho, L. H., Sano, G., Hafalla, J. C., Morrot, A., Curotto de Lafaille, M. A., and Zavala, F. (2002). IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages. Nat Med. 8, 166-170. doi: 10.1038/nm0202-166
12. Cerami, C., Kwakye-Berko, F., and Nussenzweig, V. (1992). Binding of malarial circumsporozoite protein to sulfatides [Gal(3-SO4)beta 1-Cer] and cholesterol-3-sulfate and its dependence on disulfide bond formation between cysteines in region II. Mol. Biochem. Parasitol. 54, 1-12. doi: 10.1016/0166-6851(92)90089-3
13. Chakravarty, S., Cockburn, I. A., Kuk, S., Overstreet, M. G., Sacci, J. B., and Zavala, F. (2007). CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 13, 1035-1041. doi: 10.1038/nm1628
14. Chuang, I., Sedegah, M., Cicatelli, S., Spring, M., Polhemus, M., Tamminga, C., et al. (2013). DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity. PLoS ONE 8:e55571. doi: 10.1371/journal.pone.0055571
15. Claassen, M. A., Janssen, H. L., and Boonstra, A. (2013). Role of T cell immunity in hepatitis C virus infections. Curr. Opin. Virol. 3, 461-467. doi: 10.1016/j.coviro.2013.05.006
16. Coban, C., Ishii, K. J., Horii, T., and Akira, S. (2007). Manipulation of host innate immune responses by the malaria parasite. Trends Microbiol. 15, 271-278. doi: 10.1016/j.tim.2007.04.003
17. Cockburn, I. A., Amino, R., Kelemen, R. K., Kuo, S. C., Tse, S. W., Radtke, A., et al. (2013). In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages. Proc. Natl. Acad. Sci. U.S.A. 110, 9090-9095. doi: 10.1073/pnas.1303858110
18. Cockburn, I. A., Chen, Y. C., Overstreet, M. G., Lees, J. R., van Rooijen, N., Farber, D. L., et al. (2010). Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites. PLoS Pathog. 6:e1000877. doi: 10.1371/journal.ppat.1000877
19. Cockburn, I. A., Tse, S. W., Radtke, A. J., Srinivasan, P., Chen, Y. C., Sinnis, P., et al. (2011). Dendritic cells and hepatocytes use distinct pathways to process protective antigen from plasmodium in vivo. PLoS Pathog. 7:e1001318. doi: 10.1371/journal.ppat.1001318
20. Cockburn, I. A., Tse, S. W., and Zavala, F. (2014). CD8+ T cells eliminate liver-stage Plasmodium berghei parasites without detectable bystander effect. Infect. Immun. 82, 1460-1464. doi: 10.1128/IAI.01500-13
21. Combe, A., Moreira, C., Ackerman, S., Thiberge, S., Templeton, T. J., and Ménard, R. (2009). TREP, a novel protein necessary for gliding motility of the malaria sporozoite. Int. J. Parasitol. 39, 489-496. doi: 10.1016/j.ijpara.2008.10.004
22. Condotta, S. A., Richer, M. J., Badovinac, V. P., and Harty, J. T. (2012). Probing CD8 T cell responses with Listeria monocytogenes infection. Adv. Immunol. 113, 51-80. doi: 10.1016/B978-0-12-394590-7.00005-1
23. Cooney, L. A., Gupta, M., Thomas, S., Mikolajczak, S., Choi, K. Y., Gibson, C., et al. (2013). Short-lived effector CD8 T cells induced by genetically attenuated malaria parasite vaccination express CD11c. Infect. Immun. 81, 4171-4181. doi: 10.1128/IAI.00871-13
24. Coppi, A., Natarajan, R., Pradel, G., Bennett, B. L., James, E. R., Roggero, M. A., et al. (2011). The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host. J. Exp. Med. 208, 341-356. doi: 10.1084/jem.20101488
25. Cotter, C., Sturrock, H. J., Hsiang, M. S., Liu, J., Phillips, A. A., Hwang, J., et al. (2013). The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet 382, 900-911. doi: 10.1016/S0140-6736(13)60310-4
26. Cummings, J. F., Spring, M. D., Schwenk, R. J., Ockenhouse, C. F., Kester, K. E., Polhemus, M. E., et al. (2010). Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Vaccine 28, 5135-5144. doi: 10.1016/j.vaccine.2009.08.046
27. Demeure, C. E., Brahimi, K., Hacini, F., Marchand, F., Péronet, R., Huerre, M., et al. (2005). Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J. Immunol. 174, 3932-3940. doi: 10.4049/jimmunol.174.7.3932
28. Depinay, N., Hacini, F., Beghdadi, W., Peronet, R., and Mécheri, S. (2006). Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites. J. Immunol. 176, 4141-4146. doi: 10.4049/jimmunol.176.7.4141
29. Dinparast Djadid, N., Jazayeri, H., Raz, A., Favia, G., Ricci, I., and Zakeri, S. (2011). Identification of the midgut microbiota of An. stephensi and An. maculipennis for their application as a paratransgenic tool against malaria. PLoS ONE 6:e28484. doi: 10.1371/journal.pone.0028484
30. Doolan, D. L., and Hoffman, S. L. (1999). IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. J. Immunol. 163, 884-892.
31. Doolan, D. L., and Hoffman, S. L. (2000). The complexity of protective immunity against liver-stage malaria. J. Immunol. 165, 1453-1462. doi: 10.4049/jimmunol.165.3.1453
32. Doolan, D. L., and Martinez-Alier, N. (2006). Immune response to pre-erythrocytic stages of malaria parasites. Curr. Mol. Med. 6, 169-185. doi: 10.2174/156652406776055249
33. Duffy, P. E., Sahu, T., Akue, A., Milman, N., and Anderson, C. (2012). Pre-erythrocytic malaria vaccines: identifying the targets. Expert Rev. Vaccines 11, 1261-1280. doi: 10.1586/erv.12.92
34. Ebrahimkhani, M. R., Mohar, I., and Crispe, I. N. (2011). Cross-presentation of antigen by diverse subsets of murine liver cells. Hepatology 54, 1379-1387. doi: 10.1002/hep.24508
35. Epstein, J. E., Tewari, K., Lyke, K. E., Sim, B. K., Billingsley, P. F., Laurens, M. B., et al. (2011). Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science 334, 475-480. doi: 10.1126/science.1211548
36. Erdman, L. K., Finney, C. A., Liles, W. C., and Kain, K. C. (2008). Inflammatory pathways in malaria infection: TLRs share the stage with other components of innate immunity. Mol. Biochem. Parasitol. 162, 105-111. doi: 10.1016/j.molbiopara.2008.08.006
37. Ewer, K. J., O'Hara, G. A., Duncan, C. J., Collins, K. A., Sheehy, S. H., Reyes-Sandoval, A., et al. (2013). Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nat Commun. 4, 2836. doi: 10.1038/ncomms3836
38. Fehres, C. M., Garcia-Vallejo, J. J., Unger, W. W., and van Kooyk, Y. (2013). Skin-resident antigen-presenting cells: instruction manual for vaccine development. Front. Immunol. 4:157. doi: 10.3389/fimmu.2013.00157
39. Ferraro, B., Talbott, K. T., Balakrishnan, A., Cisper, N., Morrow, M. P., Hutnick, N. A., et al. (2013). Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNA. Infect. Immun. 81, 3709-3720. doi: 10.1128/IAI.00180-13
40. Franklin, B. S., Parroche, P., Ataíde, M. A., Lauw, F., Ropert, C., de Oliveira, et al. (2009). Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function. Proc. Natl. Acad. Sci. U.S.A.106, 5789-5794. doi: 10.1073/pnas.0809742106
41. Frevert, U., and Nardin, E. (2008). Cellular effector mechanisms against Plasmodium liver stages. Cell. Microbiol. 10, 1956-1967. doi: 10.1111/j.1462-5822.2008.01211.x
42. Fu, Y., Ding, Y., Zhou, T., Fu, X., and Xu, W. (2012). Plasmodium yoelii blood-stage primes macrophage-mediated innate immune response through modulation of toll-like receptor signalling. Malar J. 11:104. doi: 10.1186/1475-2875-11-104
43. Gbédandé, K., Varani, S., Ibitokou, S., Houngbegnon, P., Borgella, S., Nouatin, O., et al. (2013). Malaria modifies neonatal and early-life toll-like receptor cytokine responses. Infect. Immun. 81, 2686-2696. doi: 10.1128/IAI.00237-13
44. Gebhardt, T., and Mackay, L. K. (2012). Local immunity by tissue-resident CD8(+) memory T cells. Front. Immunol. 3:340. doi: 10.3389/fimmu.2012.00340
45. Gowda, D. C. (2007). TLR-mediated cell signaling by malaria GPIs. Trends Parasitol. 23, 596-604. doi: 10.1016/j.pt.2007.09.003
46. Gowda, N. M., Wu, X., and Gowda, D. C. (2012). TLR9 and MyD88 are crucial for the development of protective immunity to malaria. J. Immunol. 188, 5073-5085. doi: 10.4049/jimmunol.1102143
47. Greene, J. A., Moormann, A. M., Vulule, J., Bockarie, M. J., Zimmerman, P. A., and Kazura, J. W. (2009). Toll-like receptor polymorphisms in malaria-endemic populations. Malar. J. 8:50. doi: 10.1186/1475-2875-8-50
48. Guebre-Xabier, M., Schwenk, R., and Krzych, U. (1999). Memory phenotype CD8(+) T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium berghei sporozoites. Eur. J. Immunol. 29, 3978-3986.
49. Gueirard, P., Tavares, J., Thiberge, S., Bernex, F., Ishino, T., Milon, G., et al. (2010). Development of the malaria parasite in the skin of the mammalian host. Proc. Natl. Acad. Sci. U.S.A. 107, 18640-18645. doi: 10.1073/pnas.1009346107
50. Hafalla, J. C., Bauza, K., Friesen, J., Gonzalez-Aseguinolaza, G., Hill, A. V., and Matuschewski, K. (2013). Identification of targets of CD8+ T cell responses to malaria liver stages by genome-wide epitope profiling. PLoS Pathog. 9:e1003303. doi: 10.1371/journal.ppat.1003303
51. Hafalla, J. C., Morrot, A., Sano, G., Milon, G., Lafaille, J. J., and Zavala, F. (2003). Early self-regulatory mechanisms control the magnitude of CD8+ T cell responses against liver stages of murine malaria. J. Immunol. 171, 964-970. doi: 10.4049/jimmunol.171.2.964
52. Hafalla, J. C., Sano, G., Carvalho, L. H., Morrot, A., and Zavala, F. (2002). Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages. Proc. Natl. Acad. Sci. U.S.A. 99, 11819-11824. doi: 10.1073/pnas.182189999
53. Hayashi, H, Kyushiki, H, Nagano, K, Sudo, T, Matsuoka, H, and Yoshida, S. (2012). Anopheline anti-platelet protein from a malaria vector mosquito has anti-thrombotic effects in vivo without compromising hemostasis. Thromb. Res. 129, 169-175. doi: 10.1016/j.thromres.2011.09.015
54. Henri, S., Guilliams, M., Poulin, L. F., Tamoutounour, S., Ardouin, L., Dalod, M., et al. (2010). Disentangling the complexity of the skin dendritic cell network. Immunol. Cell Biol. 88, 366-375. doi: 10.1038/icb.2010.34
55. Hill, A. V. (2011). Vaccines against malaria. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 366, 2806-2814. doi: 10.1098/rstb.2011.0091
56. Hill, A. V., Elvin, J., Willis, A. C., Aidoo, M., Allsopp, C. E., Gotch, F. M., et al. (1992). Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360, 434-439. doi: 10.1038/360434a0
57. Hill, A. V., Reyes-Sandoval, A., O'Hara, G., Ewer, K., Lawrie, A., Goodman, A., et al. (2010). Prime-boost vectored malaria vaccines: progress and prospects. Hum. Vaccin. 6, 78-83. doi: 10.4161/hv.6.1.10116
58. Ishino, T., Chinzei, Y., and Yuda, M. (2005). A Plasmodium sporozoite protein with a membrane attack complex domain is required for breaching the liver sinusoidal cell layer prior to hepatocyte infection. Cell. Microbiol. 7, 199-208. doi: 10.1111/j.1462-5822.2004.00447.x
59. Ishino, T., Yano, K., Chinzei, Y., and Yuda, M. (2004). Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer. PLoS Biol. 2:E4. doi: 10.1371/journal.pbio.0020004
60. Jiang, J., Alvarez, C., Kukutla, P., Yu, W., and Xu, J. (2012). Draft genome sequences of Enterobacter sp. isolate Ag1 from the midgut of the malaria mosquito Anopheles gambiae. J. Bacteriol. 194, 5481. doi: 10.1128/JB.01275-12
61. Kariu, T., Ishino, T., Yano, K., Chinzei, Y., and Yuda, M. (2006). CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts. Mol. Microbiol. 59, 1369-1379. doi: 10.1111/j.1365-2958.2005.05024.x
62. Khan, S. M., and Waters, A. P. (2004). Malaria parasite transmission stages: an update. Trends Parasitol. 20, 575-580. doi: 10.1016/j.pt.2004.10.001
63. Khusmith, S., Charoenvit, Y., Kumar, S., Sedegah, M., Beaudoin, R. L., and Hoffman, S. L. (1991). Protection against malaria by vaccination with sporozoite surface protein 2 plus CSprotein. Science 252, 715-718. doi: 10.1126/science.1827210
64. Krzych, U., and Schwenk, J. (2005). The dissection of CD8 T cells during liver-stage infection. Curr. Top. Microbiol. Immunol. 297, 1-24. doi: 10.1007/3-540-29967-X_1
65. Krzych, U., Zarling, S., and Pichugin, A. (2014). Memory T cells maintain protracted protection against malaria. Immunol. Lett. doi: 10.1016/j.imlet.2014.03.011. [Epub ahead of print].
66. Kumar, K. A., Sano, G., Boscardin, S., Nussenzweig, R. S., Nussenzweig, M. C., Zavala, F., et al. (2006). The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444, 937-940. doi: 10.1038/nature05361
67. Ma, J., Trop, S., Baer, S., Rakhmanaliev, E., Arany, Z., Dumoulin, P., et al. (2013). Dynamics of the major histocompatibility complex class I processing and presentation pathway in the course of malaria parasite development in human hepatocytes: implications for vaccine development. PLoS ONE 8:e75321. doi: 10.1371/journal.pone.0075321
68. Mecheri, S. (2012). Contribution of allergic inflammatory response to the pathogenesis of malaria disease. Biochim. Biophys. Acta 1822, 49-56. doi: 10.1016/j.bbadis.2011.02.005
69. Ménard, R., Tavares, J., Cockburn, I., Markus, M., Zavala, F., and Amino, R. (2013). Looking under the skin: the first steps in malarial infection and immunity. Nat. Rev. Microbiol. 11, 701-712. doi: 10.1038/nrmicro3111
70. Mikolajczak, S. A., Silva-Rivera, H., Peng, X., Tarun, A. S., Camargo, N., Jacobs-Lorena, V., et al. (2008). Distinct malaria parasite sporozoites reveal transcriptional changes that cause differential tissue infection competence in the mosquito vector and mammalian host. Mol. Cell. Biol. 28, 6196-6207. doi: 10.1128/MCB.00553-08
71. Miller, L. H., Ackerman, H. C., Su, X. Z., and Wellems, T. E. (2013). Malaria biology and disease pathogenesis: insights for new treatments. Nat. Med. 19, 156-167. doi: 10.1038/nm.3073
72. Moreira, C. K., Templeton, T. J., Lavazec, C., Hayward, R. E., Hobbs, C. V., Kroeze, H., et al. (2008). The Plasmodium TRAP/MIC2 family member, TRAP-Like Protein (TLP), is involved in tissue traversal by sporozoites. Cell. Microbiol. 10, 1505-1516. doi: 10.1111/j.1462-5822.2008.01143.x
73. Morrot, A., Hafalla, J. C., Cockburn, I. A., Carvalho, L. H., and Zavala, F. (2005). IL-4 receptor expression on CD8+ T cells is required for the development of protective memory responses against liver stages of malaria parasites. J. Exp. Med. 202, 551-560. doi: 10.1084/jem.20042463
74. Naik, R. S., Branch, O. H., Woods, A. S., Vijaykumar, M., Perkins, D. J., Nahlen, B. L., et al. (2000). Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J. Exp. Med. 192, 1563-1576. doi: 10.1084/jem.192.11.1563
75. γ responses of hepatic CD8+ memory T cells. PLoS ONE 7:e36508. doi: 10.1371/journal.pone.0036508
76. Ngwa, C. J., Glöckner, V., Abdelmohsen, U. R., Scheuermayer, M., Fischer, R., Hentschel, U., et al. (2013). 16S rRNA gene-based identification of Elizabethkingia meningoseptica (Flavobacteriales: Flavobacteriaceae) as a dominant midgut bacterium of the Asian malaria vector Anopheles stephensi (Dipteria: Culicidae) with antimicrobial activities. J. Med. Entomol. 50, 404-414. doi: 10.1603/ME12180
77. Pichyangkul, S., Kum-Arb, U., Yongvanitchit, K., Limsalakpetch, A., Gettayacamin, M., Lanar, D. E., et al. (2008). Preclinical evaluation of the safety and immunogenicity of a vaccine consisting ofPlasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS, S/AS01B vaccine in rhesus primates. Infect. Immun. 76, 229-238. doi: 10.1128/IAI.00977-07
78. Plebanski, M., Hannan, C. M., Behboudi, S., Flanagan, K. L., Apostolopoulos, V., Sinden, R. E., et al. (2005). Direct processing and presentation of antigen from malaria sporozoites by professional antigen-presenting cells in the induction of CD8 T-cell responses. Immunol. Cell Biol. 83, 307-312. doi: 10.1111/j.1440-1711.2005.01325.x
79. Prudêncio, M., Rodriguez, A., and Mota, M. M. (2006). The silent path to thousands of merozoites: the Plasmodium liver stage. Nat. Rev. Microbiol. 4, 849-856. doi: 10.1038/nrmicro1529
80. Remakus, S., and Sigal, L. J. (2013). Memory CD8+ T cell protection. Adv. Exp. Med. Biol. 785, 77-86. doi: 10.1007/978-1-4614-6217-0_9
81. Remarque, E. J., Faber, B. W., Kocken, C. H., and Thomas, A. W. (2008). Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol. 24, 74-84. doi: 10.1016/j.pt.2007.12.002
82. Rodríguez, A., Mintardjo, R., Tax, D., Gillissen, G., Custers, J., Pau, M. G., et al. (2009). Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys. Vaccine 27, 6226-6233. doi: 10.1016/j.vaccine.2009.07.106
83. Rosinski-Chupin, I., Chertemps, T., Boisson, B., Perrot, S., Bischoff, E., Briolay, J., et al. (2007). Serial Analysis of Gene Expression in Plasmodium berghei salivary glandsporozoites. BMC Genomics 8:466. doi: 10.1186/1471-2164-8-466
84. Sano, G., Hafalla, J. C., Morrot, A., Abe, R., Lafaille, J. J., and Zavala, F. (2001). Swift development of protective effector functions in naive CD8(+) T cells against malaria liver stages. J. Exp. Med. 194, 173-180. doi: 10.1084/jem.194.2.173
85. Schmidt, N. W., Podyminogin, R. L., Butler, N. S., Badovinac, V. P., Tucker, B. J., Bahjat, K. S., et al. (2008). Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc. Natl. Acad. Sci. U.S.A. 105, 14017-14022. doi: 10.1073/pnas.0805452105
86. Schofield, L., Villaquiran, J., Ferreira, A., Schellekens, H., Nussenzweig, R., and Nussenzweig, V. (1987). Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330, 664-666. doi: 10.1038/330664a0
87. Schussek, S., Trieu, A., Apte, S. H., Sidney, J., Sette, A., and Doolan, D. L. (2013). Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model. Infect. Immun. 81, 3586-3599. doi: 10.1128/IAI.00544-13
88. Schwenk, R., Banania, G., Epstein, J., Kim, Y., Peters, B., Belmonte, M., et al. (2013). Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vectored malaria vaccine expressing AMA1. Malar. J. 12:376. doi: 10.1186/1475-2875-12-376
89. Seder, R. A., Chang, L. J., Enama, M. E., Zephir, K. L., Sarwar, U. N., Gordon, I. J., et al. (2013). VRC 312 Study Team. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341, 1359-1365. doi: 10.1126/science.1241800
90. Seguin, M. C., Klotz, F. W., Schneider, I., Weir, J. P., Goodbary, M., Slayter, M., et al. (1994). Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. J. Exp. Med. 180, 353-358. doi: 10.1084/jem.180.1.353
91. Sheehy, S. H., Duncan, C. J., Elias, S. C., Choudhary, P., Biswas, S., Halstead, F. D., et al. (2012). ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans. Mol. Ther. 20, 2355-2368. doi: 10.1038/mt.2012.223
92. Shrikant, P. A., Rao, R., Li, Q., Kesterson, J., Eppolito, C., Mischo, A., et al. (2010). Regulating functional cell fates in CD8 T cells. Immunol. Res. 46, 12-22. doi: 10.1007/s12026-009-8130-9
93. Singh, A. P., Buscaglia, C. A., Wang, Q., Levay, A., Nussenzweig, D. R., Walker, J. R., et al. (2007). Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell 131, 492-504. doi: 10.1016/j.cell.2007.09.013
94. Sinnis, P., and Zavala, F. (2012). The skin: where malaria infection and the host immune response begin. Semin. Immunopathol. 34, 787-792. doi: 10.1007/s00281-012-0345-5
95. Soares, I. S., Françoso, K. S., Jampaulo, V. O., and Rodrigues, M. M. (2012). CD8(+) T-cell-mediated immunity against malaria: a novel heterologous prime-boost strategy. Expert Rev. Vaccines 11, 1039-1041. doi: 10.1586/erv.12.82
96. Spring, M., Murphy, J., Nielsen, R., Dowler, M., Bennett, J. W., Zarling, S., et al. (2013). First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers. Vaccine 31, 4975-4983. doi: 10.1016/j.vaccine.2013.08.007
97. Sultan, A. A., Thathy, V., Frevert, U., Robson, K. J., Crisanti, A., Nussenzweig, V., et al. (1997). TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites. Cell 90, 511-522. doi: 10.1016/S0092-8674(00)80511-5
98. Teixeira, L. H., Tararam, C. A., Lasaro, M. O., Camacho, A. G., Ersching, J., Leal, M. T., et al. (2014). Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents. Infect. Immun. 82, 793-807. doi: 10.1128/IAI.01410-13
99. Tse, S. W., Cockburn, I. A., Zhang, H., Scott, A. L., and Zavala, F. (2013). Unique transcriptional profile of liver-resident memory CD8+ T cells induced by immunization with malaria sporozoites. Genes Immun. 14, 302-309. doi: 10.1038/gene.2013.20
100. Vanderberg, J. P. (2014). Imaging mosquito transmission of Plasmodium sporozoites into the mammalian host: immunological implications. Parasitol. Int. 63, 150-164. doi: 10.1016/j.parint.2013.09.010
101. Wang, Y., Gilbreath, T. M., Kukutla, P., Yan, G., and Xu, J. (2011). Dynamic gut microbiome across life history of the malaria mosquito Anopheles gambiae in Kenya. PLoS ONE 6:e24767. doi: 10.1371/journal.pone.0024767
102. Weiss, W. R., Sedegah, M., Beaudoin, R. L., Miller, L. H., and Good, M. F. (1988). CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. U.S.A. 85, 573-576. doi: 10.1073/pnas.85.2.573
103. Weiss, W. R., Sedegah, M., Berzofsky, J. A., and Hoffman, S. L. (1993). The role of CD4+ T cells in immunity to malaria sporozoites. J. Immunol. 151, 2690-6908.
104. White, N. J., Pukrittayakamee, S., Hien, T. T., Faiz, M. A., Mokuolu, O. A., and Dondorp, A. M. (2014). Malaria. Lancet 383, 723-735. doi: 10.1016/S0140-6736(13)60024-0
105. WHO Malaria Policy Advisory Committee Secretariat. (2013). Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting. Malar. J. 12:456. doi: 10.1186/1475-2875-12-456
106. Wright, G. J., and Rayner, J. C. (2014). Plasmodium falciparum erythrocyte invasion: combining function with immune evasion. PLoS Pathog. 10:e1003943. doi: 10.1371/journal.ppat.1003943
107. Yamauchi, L. M., Coppi, A., Snounou, G., and Sinnis, P. (2007). Plasmodium sporozoites trickle out of the injection site. Cell. Microbiol. 9, 1215-1222. doi: 10.1111/j.1462-5822.2006.00861.x
108. Zavala, F., Tam, J. P., Hollingdale, M. R., Cochrane, A. H., Quakyi, I., Nussenzweig, R. S., et al. (1985). Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science 228, 1436-1440. doi: 10.1126/science.2409595